(Q35990141)

English

Role of VHL gene mutation in human cancer

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

title

Role of VHL gene mutation in human cancer (English)

1 reference

stated in

Europe PubMed Central

11 August 2017

2

William G Kaelin

1 reference

stated in

Europe PubMed Central

11 August 2017

William Y Kim

1

1 reference

stated in

Europe PubMed Central

PubMed ID

15611513

retrieved

11 August 2017

language of work or name

English

0 references

publication date

1 December 2004

1 reference

stated in

Europe PubMed Central

11 August 2017

Journal of Clinical Oncology

1 reference

stated in

Europe PubMed Central

11 August 2017

22

1 reference

stated in

Europe PubMed Central

11 August 2017

4991-5004

1 reference

stated in

Europe PubMed Central

11 August 2017

24

1 reference

stated in

Europe PubMed Central

11 August 2017

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/20459

Mutations of the VHL tumour suppressor gene in renal carcinoma

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NG0594-85

The Rbx1 subunit of SCF and VHL E3 ubiquitin ligase activates Rub1 modification of cullins Cdc53 and Cul2

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

A clinical and molecular genetic analysis of solitary ocular angioma

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Germ-line mutations in nonsyndromic pheochromocytoma

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Role of transforming growth factor-alpha in von Hippel--Lindau (VHL)(-/-) clear cell renal carcinoma cell proliferation: a possible mechanism coupling VHL tumor suppressor inactivation and tumorigenesis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Characterization and comparative analysis of the EGLN gene family

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Solitary retinal capillary hemangioma: lack of genetic evidence for von Hippel-Lindau disease

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Renal Cell Carcinoma With Erythrocytosis and Elevated Erythropoietic Stimulatory Activity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Transcription-dependent nuclear-cytoplasmic trafficking is required for the function of the von Hippel-Lindau tumor suppressor protein

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Inhibition of insulin-like growth factor-I-mediated cell signaling by the von Hippel-Lindau gene product in renal cancer

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

The pressure rises: update on the genetics of phaeochromocytoma

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Paradoxical secondary polycythemia in von Hippel-Lindau patients treated with anti-vascular endothelial growth factor receptor therapy

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

The DNA-repair protein AlkB, EGL-9, and leprecan define new families of 2-oxoglutarate- and iron-dependent dioxygenases

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Carboxyl-terminal transactivation activity of hypoxia-inducible factor 1 alpha is governed by a von Hippel-Lindau protein-independent, hydroxylation-regulated association with p300/CBP.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Ubiquitination of a novel deubiquitinating enzyme requires direct binding to von Hippel-Lindau tumor suppressor protein

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Hypoxia inducible factor activates the transforming growth factor-alpha/epidermal growth factor receptor growth stimulatory pathway in VHL(-/-) renal cell carcinoma cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivating mutations

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Molecular mechanisms of transcription activation by HLF and HIF1alpha in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau disease

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Tumour suppression by the human von Hippel-Lindau gene product

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Comprehensive mutational analysis of the VHL gene in sporadic renal cell carcinoma: relationship to clinicopathological parameters

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Functional consequences of a SDHB gene mutation in an apparently sporadic pheochromocytoma

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Inhibition of HIF2alpha is sufficient to suppress pVHL-defective tumor growth

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Multiple splice variants of the human HIF-3 alpha locus are targets of the von Hippel-Lindau E3 ubiquitin ligase complex

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

The VHL protein recruits a novel KRAB-A domain protein to repress HIF-1alpha transcriptional activity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

von Hippel-Lindau Protein Induces Hypoxia-regulated Arrest of Tyrosine Hydroxylase Transcript Elongation in Pheochromocytoma Cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Receptor tyrosine kinases: the main targets for new anticancer therapy

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

von Hippel-Lindau disease

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Identification of the von Hippel-Lindau disease tumor suppressor gene

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Über eine sehr seltene Erkrankung der Netzhaut

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

A second major native von Hippel-Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Germline mutations in the vhl gene in patients presenting with phaeochromocytomas.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

The contribution of VHL substrate binding and HIF1-alpha to the phenotype of VHL loss in renal cell carcinoma

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

The von Hippel-Lindau tumor suppressor gene is required for cell cycle exit upon serum withdrawal

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Alternate choice of initiation codon produces a biologically active product of the von Hippel Lindau gene with tumor suppressor activity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Nuclear/cytoplasmic localization of the von Hippel-Lindau tumor suppressor gene product is determined by cell density

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Molecular genetic analysis of the von Hippel-Lindau disease tumor suppressor gene in familial and sporadic cerebellar hemangioblastomas

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

von Hippel-Lindau protein binds hyperphosphorylated large subunit of RNA polymerase II through a proline hydroxylation motif and targets it for ubiquitination

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Renal Tumors in the Birt-Hogg-Dubé Syndrome

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Up-regulation of vascular endothelial growth factor in stromal cells of hemangioblastomas is correlated with up-regulation of the transcription factor HRF/HIF-2alpha

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1alpha

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

The von Hippel-Lindau tumor suppressor gene inhibits hepatocyte growth factor/scatter factor-induced invasion and branching morphogenesis in renal carcinoma cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Inhibition of transcription elongation by the VHL tumor suppressor protein

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Von Hippel-Lindau gene alterations in sporadic benign and malignant pheochromocytomas

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

von Hippel-Lindau disease gene deletion detected in microdissected sporadic human colon carcinoma specimens.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

VHL induces renal cell differentiation and growth arrest through integration of cell-cell and cell-extracellular matrix signaling

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Regulation of tyrosine hydroxylase promoter activity by the von Hippel-Lindau tumor suppressor protein and hypoxia-inducible transcription factors

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Molecular genetic analysis of the von Hippel-Lindau disease (VHL) tumour suppressor gene in gonadal tumours

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

SCF and Cullin/Ring H2-based ubiquitin ligases

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Novel mutations and the emergence of a common mutation in the SDHD gene causing familial paraganglioma

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Reconsideration of biallelic inactivation of the VHL tumour suppressor gene in hemangioblastomas of the central nervous system

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Activation of Sp1-mediated vascular permeability factor/vascular endothelial growth factor transcription requires specific interaction with protein kinase C zeta

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Induction of angiogenesis in a mouse model using engineered transcription factors

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

ZUR FRAGE DER ANGIOMATOSIS RETINae UND IHRER HIRNKOMPLIKATIONEN

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Mutation of the Von Hippel-Lindau tumour suppressor gene in capillary haemangioblastomas of the central nervous system

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Expression of the von Hippel-Lindau disease tumour suppressor gene during human embryogenesis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

The von Hippel-Lindau tumor suppressor stabilizes novel plant homeodomain protein Jade-1

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

pVHL19 is a biologically active product of the von Hippel-Lindau gene arising from internal translation initiation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Putative control of angiogenesis in hemangioblastomas by the von Hippel-Lindau tumor suppressor gene.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Expression of vascular endothelial growth factor in capillary hemangioblastoma.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Activation of Hypoxia-inducible Factor-1; Definition of Regulatory Domains within the α Subunit

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Extensive mutation scanning of RET in sporadic medullary thyroid carcinoma and of RET and VHL in sporadic pheochromocytoma reveals involvement of these genes in only a minority of cases

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1alpha

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

The von Hippel-Lindau tumor suppressor protein mediates ubiquitination of activated atypical protein kinase C.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Structure of an HIF-1alpha -pVHL complex: hydroxyproline recognition in signaling

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Vascular endothelial growth factor overexpression is correlated with von Hippel-Lindau tumor suppressor gene inactivation in patients with sporadic renal cell carcinoma

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Differential Genetic Alterations in von Hippel-Lindau Syndrome-Associated and Sporadic Pheochromocytomas

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Mutation of the VHL gene is associated exclusively with the development of non-papillary renal cell carcinomas

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Expression of hypoxia-inducible factor 1? in brain tumors

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Identification of a deubiquitinating enzyme subfamily as substrates of the von Hippel-Lindau tumor suppressor

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Isolation and characterization of the full-length 3' untranslated region of the human von Hippel-Lindau tumor suppressor gene

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

HIF-1 and mechanisms of hypoxia sensing

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1alpha/VP16 hybrid transcription factor

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHL

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Sporadic phaeochromocytomas are rarely associated with germline mutations in the von Hippel-Lindau and RET genes

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Rapid and durable recovery of visual function in a patient with von hippel-lindau syndrome after systemic therapy with vascular endothelial growth factor receptor inhibitor su5416.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Mutations in the VHL gene in sporadic apparently congenital polycythemia

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Extensive mutation scanning of RET in sporadic medullary thyroid carcinoma and of RET and VHL in sporadic pheochromocytoma reveals involvement of these genes in only a minority of cases.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Germline mutation profile of theVHL gene in von Hippel-Lindau disease and in sporadic hemangioblastoma

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

[Hippel-Lindau syndrome and sporadic renal cell carcinomas. Pathogenesis, morphologic spectrum and molecular genetics]

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Hematological study on a case with cerebellar hemangioblastoma associated with erythrocytosis, with special reference to a erythropoiesis-stimulating activity present in the fluid of the cyst of tumor

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Chief cell hyperplasia in the human carotid body at high altitudes; physiologic and pathologic significance

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

A role for mitochondrial enzymes in inherited neoplasia and beyond

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Direct Interaction of the β-Domain of VHL Tumor Suppressor Protein with the Regulatory Domain of Atypical PKC Isotypes

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Mutations of the VHL gene in sporadic renal cell carcinoma: definition of a risk factor for VHL patients to develop an RCC

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

A conserved family of prolyl-4-hydroxylases that modify HIF

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Expression of growth factors and growth factor receptors in capillary hemangioblastoma

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Familial non-VHL non-papillary clear-cell renal cancer

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Erythropoietin, tumours and the von Hippel-Lindau gene: towards identification of mechanisms and dysfunction of oxygen sensing

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Analysis of von Hippel—Lindau mutations with comparative genomic hybridization in sporadic and hereditary hemangioblastomas: possible genetic heterogeneity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1200/JCO.2004.05.061

Identifiers

DOI

10.1200/JCO.2004.05.061

1 reference

stated in

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

PubMed ID

15611513

retrieved

11 August 2017

(Q35990141)

Role of VHL gene mutation in human cancer

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)